(Q53509178)
Statements
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. (English)
1 reference
1 reference
1 reference
Butturini G
1 reference
Bettini R
1 reference
Missiaglia E
1 reference
Mantovani W
1 reference
Dalai I
1 reference
Capelli P
1 reference
Ferdeghini M
1 reference
Pederzoli P
1 reference
1 December 2006
1 reference
13
1 reference
1213-1221
1 reference
4
1 reference
Identifiers
1 reference